News from synthetic biologics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 28, 2014, 06:56 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile

Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause...

Aug 26, 2014, 06:58 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics Announces Presentation of Poster for SYN-004 C. difficile Program at IDWeek 2014™

 Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting...

Aug 19, 2014, 06:56 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC

 Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting...

Aug 14, 2014, 06:58 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics Reports Second Quarter 2014 Financial Results and Operational Highlights

Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause...

Aug 13, 2014, 06:56 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics to Host Irritable Bowel Syndrome (IBS) Investor Day

Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific...

Aug 12, 2014, 06:58 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics' Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treatment of Whooping Cough (Pertussis) at 54th ICAAC

 Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting...

Aug 07, 2014, 06:56 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics to Report Second Quarter 2014 Financial Results

 Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting...

Aug 05, 2014, 06:58 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics on Track to Initiate Clinical Program for SYN-004 to Protect Against C. difficile

 Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that...

Jul 31, 2014, 06:57 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Expanded Data on Disability and Cognitive Improvements in Phase II Study of Synthetic Biologics' Trimesta™ in Multiple Sclerosis to be Presented at 2014 Joint ACTRIMS-ECTRIMS Meeting

Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific...

Jul 29, 2014, 13:28 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity

 Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that...

Jul 21, 2014, 06:58 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics' Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treating Whooping Cough (Pertussis) at Gordon Research Conference

Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause...

Jun 30, 2014, 06:57 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics Forms Clinical Advisory Board to Support Novel C. difficile Preventative Program

 Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that...

Jun 25, 2014, 06:57 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics Reports that Licensor Cedars-Sinai Finds Eradication of Gut Methane Improves Insulin Sensitivity and Lipid Profiles in Study of Pre-Diabetic, Obese Patients

ROCKVILLE, Md., June 25, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug...

Jun 10, 2014, 03:00 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics and Enterome Bioscience Collaborate on Microbiome Research to Support Synthetic Biologics' C. difficile Program

 Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that...

May 20, 2014, 14:48 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics to Present at the 3rd Annual Marcum LLP MicroCap Conference

 Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of anti-infective biologic and drug candidates targeting specific pathogens that cause...

May 15, 2014, 06:56 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics Reports First Quarter 2014 Financial Results and Operational Highlights

 Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that...

May 09, 2014, 06:57 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics to Report First Quarter 2014 Financial Results

Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause...

May 08, 2014, 06:58 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics Announces Recent International Patents that Bolster its C. difficile Program

 Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that...

Apr 30, 2014, 06:58 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics to Discuss Phase II Results of Oral Estriol Candidate Trimesta™ for Relapsing-Remitting Multiple Sclerosis in Women

 Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that...

Apr 29, 2014, 15:45 ET
Synthetic Biologics, Inc. Logo.  (PRNewsFoto/Synthetic Biologics, Inc.)

Synthetic Biologics Reports UCLA Announcement of Preliminary Positive Topline Efficacy and Safety Results from Investigator-Led Phase II Study of Trimesta™ for Relapsing-Remitting Multiple Sclerosis

Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause...